Search

Anne Searls Degroot

from Dartmouth, MA
Age ~68
Get Report
Also known as:
Anne S Degroot, Anne D Degroot, Anne S Groot, Annie S Degroot, Anne Dr Groot
Phone and address:
14 Bayview Ave, Dartmouth, MA 02748
Related to:
Searls De GrootAminata Degroot, 32
Connected to:
Agnes E Degroot, 67Amber N Degroot, 42Bruce R Degroot, 67Carl Degroot, 106Carol L Degroot, 55Charlene G Degroot, 45Chris Degroot, 46Christina C Degroote, 48Craig R Degroot, 57Cynthia M Degroot, 48

Anne Degroot Phones & Addresses

  • 14 Bayview Ave, S Dartmouth, MA 02748
  • Dartmouth, MA
  • 292 Morris Ave, Providence, RI 02906 (860) 338-6328
  • Phoenix, AZ
  • Roslindale, MA
  • Washington, DC

Professional Records

License Records

Anne S. Degroot

Address:
Providence, RI
Phone:
(401) 272-2123 (Work)
(401) 272-7562 (Fax)
License #:
MD08278 - Active
Category:
Physician
Issued Date:
Oct 8, 1992
Expiration Date:
Jun 30, 2018
Type:
Allopathic Physician (MD)

Business Records

Name / Title
Company / Classification
Phones & Addresses
Anne Degroot
DIRECTOR
MOLECULAR MACHINES, INC
DEVELOPING MOLECULAR VACCINE AND THERAPEUTIC DRUG CANDIDATES.
292 Morris Ave, Providence, RI 02906
Anne S Degroot
Treasurer
EpiVax, Inc.
Biotechnology · To Engage In The Business Of Developing Vaccine And Therapeautic Drug Candidates And Related Research And Development. · Mfg Non Diagnostic Biological Preparations Individual or Family Social Srvcs · Internist · Research & Development in Biotechnology
146 Clifford St, Providence, RI 02903
(401) 272-2123, (401) 272-7562

Publications

Us Patents

Immunogenic, Cross-Clade, Hiv Peptides

View page
US Patent:
20030180314, Sep 25, 2003
Filed:
Jul 22, 2002
Appl. No.:
10/200708
Inventors:
Anne DeGroot - Providence RI, US
International Classification:
A61K039/29
A61K039/21
C07K014/16
US Classification:
424/188100, 530/350000
Abstract:
The invention provides Cross-clade candidates that have “evolved” due to gene shuffling in vitro for inclusion of “cross-clade” characteristics. The invention also provides a method for identifying Cross-clade candidates that could be presented in the context of more than one HLA, due to the creation of promiscuous epitopes by gene shuffling.

Novel Regulatory T Cell Epitope And Hepatitis C Virus Homolog

View page
US Patent:
20150273032, Oct 1, 2015
Filed:
Nov 19, 2014
Appl. No.:
14/547981
Inventors:
- Providence RI, US
Stephen Gregory - Providence RI, US
Anne DeGroot - Providence RI, US
William Martin - Cumberland RI, US
International Classification:
A61K 39/00
C12N 7/00
C07K 7/08
C07K 16/18
Abstract:
A pharmaceutical composition used to suppress immunity in an animal, wherein the pharmaceutical composition comprises an isolated T-cell epitope peptide containing an amino acid sequence of PLLLLLXLPXRA (SEQ ID NO: 5), wherein X is an amino acid.
Control profile
Anne Searls Degroot from Dartmouth, MA, age ~68 Get Report